# TEMOZOLOMIDE
> **ANDA205227** · Abbreviated New Drug Application (Generic) · Sponsor: EXTROVIS · Approved 2016-06-29
## Drug
- **FDA Application Number:** ANDA205227
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TEMOZOLOMIDE
- **Generic name:** Temozolomide
- **Active ingredients:** TEMOZOLOMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** EXTROVIS
- **First approval:** 2016-06-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205227)
---
*MORVS · CC0 1.0*